Levothyroxine Sodium Tablet
Product Images NDC 51655-694

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 51655-694). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label 1 (51655 453 52 Master Bottle Label Approval Rev B 04 21)

Label for Levothyroxine Sodium Tablets, USP 50 mcg (0.050 mg), oral tablets. The package contains 30 tablets. Label includes storage instructions (20°-25°C with permitted excursions), prescription-only status, NDC 51655-453-52, and manufacturer Northwind Pharmaceuticals LLC, repackaged by Northwind Health Company, LLC.*

FDA Label Image

Label 6 (51655 513 52 Master Bottle Label Approval Rev B 04 21)

Label for Levothyroxine Sodium Tablets USP 0.137 mg (137 mcg) oral tablets. The label states a quantity of 30 tablets, prescription only. Storage instructions specify 20°-25°C with permitted excursions. The label includes barcodes, NDC 51655-513-52, and manufacturer information for Northwind Pharmaceuticals LLC, repackaged by Ampneal Pharmaceuticals LLC.*

FDA Label Image

Label 4 (51655 557 52 Master Bottle Label Approval Rev A 01 21)

Label for Levothyroxine Sodium Tablets USP 112 mcg (0.112 mg) oral tablets. The package contains 30 tablets, Rx only. The label includes storage instructions, repackaging and lot information, and the labeler Northwind Health Company, LLC.*

FDA Label Image

Label 2 (51655 687 52 Master Bottle Label Approval Rev B 04 21)

Label for Levothyroxine Sodium Tablets, USP 75 mcg (0.075 mg), oral tablets. The package contains 30 tablets and is labeled Rx only. Label includes storage instructions and manufacturer information: Northwind Pharmaceuticals, repackaged from Amneal Pharmaceuticals LLC. The NDC is 51655-687-52.*

FDA Label Image

Label (51655 694 52 Master Bottle Label Approval Rev B 06 21)

Label for Levothyroxine Sodium Tablets, USP 150 mcg (0.150 mg), oral tablets in a package of 30. The label includes storage instructions, NDC 51655-694-52, and notes that it is prescription only. Manufactured by Northwind Pharmaceuticals LLC, Indianapolis, IN.*

FDA Label Image

Label 5 (51655 696 52 Master Bottle Label Approval Rev A 04 21)

Label for Levothyroxine Sodium Tablets, USP 0.125 mg (125 mcg), oral tablet dosage form. The package contains 30 tablets and is labeled for prescription use only. The label includes storage instructions and notes it is repackaged by Northwind Pharmaceuticals from Amneal Pharmaceuticals, with associated identification codes and a QR code.*

FDA Label Image

Label 3 (51655 705 52 Master Bottle Label Approval Rev A 04 21)

Label for Levothyroxine Sodium Tablets USP 88 mcg (0.088 mg), oral tablets, 30 count. The label indicates prescription use only, storage instructions (20°-25°C with permitted excursions), and repackaging information by Northwind Pharmaceuticals LLC, Indianapolis. It includes NDC 51655-705-52, lot number, expiration, and barcode details.*

FDA Label Image

Chemical Structure (Levothyroxine Sodium Tablet Usp Jsp 1)

Chemical structure of levothyroxine sodium, showing aromatic rings, hydroxyl groups, iodine atoms, and an amino acid side chain with sodium and water of hydration indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.